Laser Treatment of Reticular Leg Veins vs. Sclerotherapy
Treatment of Reticular Leg Veins: a Prospective, Randomized, Comparative Clinical Trial of a 1064 nm Nd:YAG Long Pulse Laser, Combined Treatment of a 1064 nm Nd:YAG Long Pulse Laser and Sclerotherapy vs. Sclerotherapy Alone.
Derzhavin Tambov State University
174 participants
Oct 9, 2023
INTERVENTIONAL
Conditions
Summary
Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.
Eligibility
Inclusion Criteria3
- women over 18
- reticular veins
- signed informed consent to participate in the study
Exclusion Criteria10
- diabetes mellitus
- pregnancy or lactation
- malignant neoplasms
- inability or unwillingness of the patient to wear compression stockings
- hypersensitivity to the polidocanol, cold, sunlight
- concomitant diseases: bronchial asthma, severe liver and kidney disease, acute thrombosis and thrombophlebitis, infection of the skin and/or soft tissues, infectious diseases, arteriosclerosis, diabetic angiopathy, heart defects requiring surgery, fever, toxic hyperthyroidism, obesity, tuberculosis, sepsis, violation of the cellular composition of the blood, all diseases requiring bed rest, heart disease with decompensation phenomena,
- known hereditary thrombophilia.
- period after treatment of alcoholism
- reception of oral contraceptives
- sedentary lifestyle
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser
Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, laser plus sclerotherapy
Examination, photographing, inclusion in the study, signing of informed consent, randomization, diameter measurement, sclerotherapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06175754